Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Technical aspects of intestinal transplantation.

Surgical technology international

Furukawa H, Abu-Elmagd K, Reyes J, Nour B, Tzakis A, Todo S, Starzl TE.
PMID: 25951558
Surg Technol Int. 1993 Oct;2:165-70.

Since the advent of the potent immunosuppressive agent FK 506, intestinal transplantation has become a feasible therapeutic option for patients with irreversible intestinal failure. In this chapter, we present our clinical experience with intestinal transplantation, focusing on the technical...

Cite
Furukawa H, Abu-Elmagd K, Reyes J, et al. Technical aspects of intestinal transplantation. Surg Technol Int. 1993;2:165-70
Furukawa, H., Abu-Elmagd, K., Reyes, J., Nour, B., Tzakis, A., Todo, S., & Starzl, T. E. (1993). Technical aspects of intestinal transplantation. Surgical technology international, 2165-70.
Furukawa, H, et al. "Technical aspects of intestinal transplantation." Surgical technology international vol. 2 (1993): 165-70.
Furukawa H, Abu-Elmagd K, Reyes J, Nour B, Tzakis A, Todo S, Starzl TE. Technical aspects of intestinal transplantation. Surg Technol Int. 1993 Oct;2:165-70. PMID: 25951558.
Copy Download .nbib Format: NLM
Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset.

Bioinformation

Kharrat N, Assidi M, Abu-Elmagd M, Pushparaj PN, Alkhaldy A, Arfaoui L, Naseer MI, El Omri A, Messaoudi S, Buhmeida A, Rebai A.
PMID: 31312073
Bioinformation. 2019 May 30;15(6):372-379. doi: 10.6026/97320630015372. eCollection 2019.

Gut microbiota and their metabolites play a vital role in colon health and disease. Accumulating evidence suggests that the gut microbiota contributes to the risk of colorectal cancer (CRC). However, the role of a specific microbial community together with...

Cite
Kharrat N, Assidi M, Abu-Elmagd M, et al. Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset. Bioinformation. 2019;15(6):372-379doi: 10.6026/97320630015372.
Kharrat, N., Assidi, M., Abu-Elmagd, M., Pushparaj, P. N., Alkhaldy, A., Arfaoui, L., Naseer, M. I., El Omri, A., Messaoudi, S., Buhmeida, A., & Rebai, A. (2019). Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset. Bioinformation, 15(6), 372-379. https://doi.org/10.6026/97320630015372
Kharrat, Najla, et al. "Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset." Bioinformation vol. 15,6 (2019): 372-379. doi: https://doi.org/10.6026/97320630015372
Kharrat N, Assidi M, Abu-Elmagd M, Pushparaj PN, Alkhaldy A, Arfaoui L, Naseer MI, El Omri A, Messaoudi S, Buhmeida A, Rebai A. Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset. Bioinformation. 2019 May 30;15(6):372-379. doi: 10.6026/97320630015372. eCollection 2019. PMID: 31312073; PMCID: PMC6614120.
Copy Download .nbib Format: NLM
Frizzled-7 is required for .

Biology open

Abu-Elmagd M, Mulvaney J, Wheeler GN.
PMID: 29101100
Biol Open. 2017 Dec 15;6(12):1861-1868. doi: 10.1242/bio.026963.

Wnt signalling regulates cardiogenesis during specification of heart tissue and the morphogenetic movements necessary to form the linear heart. Wnt11-mediated non-canonical signalling promotes early cardiac development whilst Wnt11-R, which is expressed later, also signals through the non-canonical pathway to...

Cite
Abu-Elmagd M, Mulvaney J, Wheeler GN. Frizzled-7 is required for . Biol Open. 2017;6(12):1861-1868doi: 10.1242/bio.026963.
Abu-Elmagd, M., Mulvaney, J., & Wheeler, G. N. (2017). Frizzled-7 is required for . Biology open, 6(12), 1861-1868. https://doi.org/10.1242/bio.026963
Abu-Elmagd, Muhammad, et al. "Frizzled-7 is required for ." Biology open vol. 6,12 (2017): 1861-1868. doi: https://doi.org/10.1242/bio.026963
Abu-Elmagd M, Mulvaney J, Wheeler GN. Frizzled-7 is required for . Biol Open. 2017 Dec 15;6(12):1861-1868. doi: 10.1242/bio.026963. PMID: 29101100; PMCID: PMC5769647.
Copy Download .nbib Format: NLM
Practical approach to linear EUS examination of the mediastinum.

Endoscopic ultrasound

Okasha HH, El-Meligui A, Pawlak KM, Żorniak M, Atalla H, Abou-Elmagd A, Abou-Elenen S, El-Husseiny R, Alzamzamy A.
PMID: 34854401
Endosc Ultrasound. 2021 Nov-Dec;10(6):406-413. doi: 10.4103/EUS-D-21-00019.

EUS has become a substantial diagnostic and therapeutic modality for many anatomical regions. The extent of endosonographic assessment is wide, and among others, allows for the evaluation of the mediastinal anatomy and related pathologies such as mediastinal lymphadenopathy and...

Cite
Okasha HH, El-Meligui A, Pawlak KM, et al. Practical approach to linear EUS examination of the mediastinum. Endosc Ultrasound. 2021;10(6):406-413doi: 10.4103/EUS-D-21-00019.
Okasha, H. H., El-Meligui, A., Pawlak, K. M., Żorniak, M., Atalla, H., Abou-Elmagd, A., Abou-Elenen, S., El-Husseiny, R., & Alzamzamy, A. (2021). Practical approach to linear EUS examination of the mediastinum. Endoscopic ultrasound, 10(6), 406-413. https://doi.org/10.4103/EUS-D-21-00019
Okasha, Hussein Hassan, et al. "Practical approach to linear EUS examination of the mediastinum." Endoscopic ultrasound vol. 10,6 (2021): 406-413. doi: https://doi.org/10.4103/EUS-D-21-00019
Okasha HH, El-Meligui A, Pawlak KM, Żorniak M, Atalla H, Abou-Elmagd A, Abou-Elenen S, El-Husseiny R, Alzamzamy A. Practical approach to linear EUS examination of the mediastinum. Endosc Ultrasound. 2021 Nov-Dec;10(6):406-413. doi: 10.4103/EUS-D-21-00019. PMID: 34854401.
Copy Download .nbib Format: NLM
The Liver and Intestinal Allocation Policy: Decades of Disparity Calling for Action.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Farmer DG, Abu-Elmagd K.
PMID: 34837465
Am J Transplant. 2021 Nov 27; doi: 10.1111/ajt.16897. Epub 2021 Nov 27.

The last three decades witnessed continual evolution of the organ allocation strategy. The Organ Procurement and Transplant Network (OPTN) primary goals were to promote patient access to transplantation and improve equity among single and multi-organ candidates. Other intended objectives...

Cite
Farmer DG, Abu-Elmagd K. The Liver and Intestinal Allocation Policy: Decades of Disparity Calling for Action. Am J Transplant. 2021;doi: 10.1111/ajt.16897.
Farmer, D. G., & Abu-Elmagd, K. (2021). The Liver and Intestinal Allocation Policy: Decades of Disparity Calling for Action. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, . https://doi.org/10.1111/ajt.16897
Farmer, Douglas G, and Abu-Elmagd, Kareem. "The Liver and Intestinal Allocation Policy: Decades of Disparity Calling for Action." American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. (2021). doi: https://doi.org/10.1111/ajt.16897
Farmer DG, Abu-Elmagd K. The Liver and Intestinal Allocation Policy: Decades of Disparity Calling for Action. Am J Transplant. 2021 Nov 27; doi: 10.1111/ajt.16897. Epub 2021 Nov 27. PMID: 34837465.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in cell and developmental biology

Kalamegam G, Alfakeeh SM, Bahmaid AO, AlHuwait EA, Gari MA, Abbas MM, Ahmed F, Abu-Elmagd M, Pushparaj PN.
PMID: 32793594
Front Cell Dev Biol. 2020 Jul 23;8:646. doi: 10.3389/fcell.2020.00646. eCollection 2020.

Chronic inflammation is a common underlying factor in osteoarthritis (OA) and most age-related degenerative diseases. As conventional therapies help only in partial alleviation of symptoms in OA, stem cell-based therapies and herbal supplements are being widely explored. Thymoquinone (TQ),...

Cite
Kalamegam G, Alfakeeh SM, Bahmaid AO, et al. . Front Cell Dev Biol. 2020;8:646doi: 10.3389/fcell.2020.00646.
Kalamegam, G., Alfakeeh, S. M., Bahmaid, A. O., AlHuwait, E. A., Gari, M. A., Abbas, M. M., Ahmed, F., Abu-Elmagd, M., & Pushparaj, P. N. (2020). . Frontiers in cell and developmental biology, 8646. https://doi.org/10.3389/fcell.2020.00646
Kalamegam, Gauthaman, et al. "." Frontiers in cell and developmental biology vol. 8 (2020): 646. doi: https://doi.org/10.3389/fcell.2020.00646
Kalamegam G, Alfakeeh SM, Bahmaid AO, AlHuwait EA, Gari MA, Abbas MM, Ahmed F, Abu-Elmagd M, Pushparaj PN. . Front Cell Dev Biol. 2020 Jul 23;8:646. doi: 10.3389/fcell.2020.00646. eCollection 2020. PMID: 32793594; PMCID: PMC7391788.
Copy Download .nbib Format: NLM
Use of chick neural tube for optimizing the PSM and epithelial somites electroporation parameters: A detailed protocol.

Journal of biological methods

Abu-Elmagd M.
PMID: 31453243
J Biol Methods. 2018 Jun 07;5(2):e93. doi: 10.14440/jbm.2018.253. eCollection 2018.

Somite myogenesis is one of the crucial early embryonic events that lead to the formation of muscular tissue. A complex of dynamic gene regulatory networks masters this event. To understand and analyze these networks, there remains a genuine need...

Cite
Abu-Elmagd M. Use of chick neural tube for optimizing the PSM and epithelial somites electroporation parameters: A detailed protocol. J Biol Methods. 2018;5(2):e93doi: 10.14440/jbm.2018.253.
Abu-Elmagd, M. (2018). Use of chick neural tube for optimizing the PSM and epithelial somites electroporation parameters: A detailed protocol. Journal of biological methods, 5(2), e93. https://doi.org/10.14440/jbm.2018.253
Abu-Elmagd, Muhammad. "Use of chick neural tube for optimizing the PSM and epithelial somites electroporation parameters: A detailed protocol." Journal of biological methods vol. 5,2 (2018): e93. doi: https://doi.org/10.14440/jbm.2018.253
Abu-Elmagd M. Use of chick neural tube for optimizing the PSM and epithelial somites electroporation parameters: A detailed protocol. J Biol Methods. 2018 Jun 07;5(2):e93. doi: 10.14440/jbm.2018.253. eCollection 2018. PMID: 31453243; PMCID: PMC6706099.
Copy Download .nbib Format: NLM
Erratum to: More Comprehensive Forensic Genetic Marker Analyses for Accurate Human Remains Identification Using Massively Parallel DNA Sequencing.

BMC genomics

Ambers AD, Churchill JD, King JL, Stoljarova M, Gill-King H, Assidi M, Abu-Elmagd M, Buhmeida A, Al-Qahtani M, Budowle B.
PMID: 28427331
BMC Genomics. 2017 Apr 20;18(1):312. doi: 10.1186/s12864-017-3648-z.

No abstract available.

Cite
Ambers AD, Churchill JD, King JL, et al. Erratum to: More Comprehensive Forensic Genetic Marker Analyses for Accurate Human Remains Identification Using Massively Parallel DNA Sequencing. BMC Genomics. 2017;18(1):312doi: 10.1186/s12864-017-3648-z.
Ambers, A. D., Churchill, J. D., King, J. L., Stoljarova, M., Gill-King, H., Assidi, M., Abu-Elmagd, M., Buhmeida, A., Al-Qahtani, M., & Budowle, B. (2017). Erratum to: More Comprehensive Forensic Genetic Marker Analyses for Accurate Human Remains Identification Using Massively Parallel DNA Sequencing. BMC genomics, 18(1), 312. https://doi.org/10.1186/s12864-017-3648-z
Ambers, Angie D, et al. "Erratum to: More Comprehensive Forensic Genetic Marker Analyses for Accurate Human Remains Identification Using Massively Parallel DNA Sequencing." BMC genomics vol. 18,1 (2017): 312. doi: https://doi.org/10.1186/s12864-017-3648-z
Ambers AD, Churchill JD, King JL, Stoljarova M, Gill-King H, Assidi M, Abu-Elmagd M, Buhmeida A, Al-Qahtani M, Budowle B. Erratum to: More Comprehensive Forensic Genetic Marker Analyses for Accurate Human Remains Identification Using Massively Parallel DNA Sequencing. BMC Genomics. 2017 Apr 20;18(1):312. doi: 10.1186/s12864-017-3648-z. PMID: 28427331; PMCID: PMC5397906.
Copy Download .nbib Format: NLM
Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction.

Transplantation

Shapiro R, Basu A, Tan HP, Morgan C, Sharma V, Blisard D, Randhawa PS, Dvorchik I, McCauley J, Ellis D, Marsh JW, Webber S, Kurland G, McCurry K, Abu-Elmagd K, Mazariegos G, Starzl TE.
PMID: 21170281
Transplantation. 2008 May;8:439.

No abstract available.

Cite
Shapiro R, Basu A, Tan HP, et al. Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction. Transplantation. 2008;8:439
Shapiro, R., Basu, A., Tan, H. P., Morgan, C., Sharma, V., Blisard, D., Randhawa, P. S., Dvorchik, I., McCauley, J., Ellis, D., Marsh, J. W., Webber, S., Kurland, G., McCurry, K., Abu-Elmagd, K., Mazariegos, G., & Starzl, T. E. (2008). Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction. Transplantation, 8439.
Shapiro, Ron, et al. "Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction." Transplantation vol. 8 (2008): 439.
Shapiro R, Basu A, Tan HP, Morgan C, Sharma V, Blisard D, Randhawa PS, Dvorchik I, McCauley J, Ellis D, Marsh JW, Webber S, Kurland G, McCurry K, Abu-Elmagd K, Mazariegos G, Starzl TE. Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction. Transplantation. 2008 May;8:439. PMID: 21170281; PMCID: PMC3002172.
Copy Download .nbib Format: NLM
Can growth hormone and glutamine reduce parenteral nutrition requirements in patients with short-bowel syndrome?.

Nature clinical practice. Gastroenterology & hepatology

Matarese LE, Abu-Elmagd K.
PMID: 16582958
Nat Clin Pract Gastroenterol Hepatol. 2006 Apr;3(4):194-5. doi: 10.1038/ncpgasthep0450.

No abstract available.

Cite
Matarese LE, Abu-Elmagd K. Can growth hormone and glutamine reduce parenteral nutrition requirements in patients with short-bowel syndrome?. Nat Clin Pract Gastroenterol Hepatol. 2006;3(4):194-5doi: 10.1038/ncpgasthep0450.
Matarese, L. E., & Abu-Elmagd, K. (2006). Can growth hormone and glutamine reduce parenteral nutrition requirements in patients with short-bowel syndrome?. Nature clinical practice. Gastroenterology & hepatology, 3(4), 194-5. https://doi.org/10.1038/ncpgasthep0450
Matarese, Laura E, and Abu-Elmagd, Kareem. "Can growth hormone and glutamine reduce parenteral nutrition requirements in patients with short-bowel syndrome?." Nature clinical practice. Gastroenterology & hepatology vol. 3,4 (2006): 194-5. doi: https://doi.org/10.1038/ncpgasthep0450
Matarese LE, Abu-Elmagd K. Can growth hormone and glutamine reduce parenteral nutrition requirements in patients with short-bowel syndrome?. Nat Clin Pract Gastroenterol Hepatol. 2006 Apr;3(4):194-5. doi: 10.1038/ncpgasthep0450. PMID: 16582958.
Copy Download .nbib Format: NLM
Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center.

World journal of transplantation

Hilmi IA, Planinsic RM, Nicolau-Raducu R, Damian D, Al-Khafaji A, Sakai T, Abu-Elmagd K.
PMID: 24392317
World J Transplant. 2013 Dec 24;3(4):127-33. doi: 10.5500/wjt.v3.i4.127.

AIM: To investigate patient and graft outcomes in isolated small bowel transplant (SBTx) recipients and immunosuppressant induction agent impact on outcomes.METHODS: A retrospective review of the perioperative data of patients who underwent SBTx transplant during an 8-year period was...

Cite
Hilmi IA, Planinsic RM, Nicolau-Raducu R, et al. Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center. World J Transplant. 2013;3(4):127-33doi: 10.5500/wjt.v3.i4.127.
Hilmi, I. A., Planinsic, R. M., Nicolau-Raducu, R., Damian, D., Al-Khafaji, A., Sakai, T., & Abu-Elmagd, K. (2013). Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center. World journal of transplantation, 3(4), 127-33. https://doi.org/10.5500/wjt.v3.i4.127
Hilmi, Ibtesam A, et al. "Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center." World journal of transplantation vol. 3,4 (2013): 127-33. doi: https://doi.org/10.5500/wjt.v3.i4.127
Hilmi IA, Planinsic RM, Nicolau-Raducu R, Damian D, Al-Khafaji A, Sakai T, Abu-Elmagd K. Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center. World J Transplant. 2013 Dec 24;3(4):127-33. doi: 10.5500/wjt.v3.i4.127. PMID: 24392317; PMCID: PMC3879522.
Copy Download .nbib Format: NLM
Clinical intestinal transplantation.

Clinical nutrition (Edinburgh, Scotland)

Furukawa H, Reyes J, Abu-Elmagd K, Todo S.
PMID: 16843997
Clin Nutr. 1996 Apr;15(2):45-52. doi: 10.1016/s0261-5614(96)80018-5.

The advent of tacrolimus allowed clinical intestinal transplantation to become a feasible procedure for patients with irreversible intestinal failure. Over last 5 years, 71 patients underwent intestinal transplantation. Forty-one recipients were children, and 30 recipients were adults. Twenty-five patients...

Cite
Furukawa H, Reyes J, Abu-Elmagd K, et al. Clinical intestinal transplantation. Clin Nutr. 1996;15(2):45-52doi: 10.1016/s0261-5614(96)80018-5.
Furukawa, H., Reyes, J., Abu-Elmagd, K., & Todo, S. (1996). Clinical intestinal transplantation. Clinical nutrition (Edinburgh, Scotland), 15(2), 45-52. https://doi.org/10.1016/s0261-5614(96)80018-5
Furukawa, H, et al. "Clinical intestinal transplantation." Clinical nutrition (Edinburgh, Scotland) vol. 15,2 (1996): 45-52. doi: https://doi.org/10.1016/s0261-5614(96)80018-5
Furukawa H, Reyes J, Abu-Elmagd K, Todo S. Clinical intestinal transplantation. Clin Nutr. 1996 Apr;15(2):45-52. doi: 10.1016/s0261-5614(96)80018-5. PMID: 16843997.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries